Skip to content
Axcess News – Lifestyle
Author:
SOLIGENIX, INC.
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease
March 6, 2026
Soligenix to Present at BIO Investment & Growth Summit
March 5, 2026
←
Previous Page
1
2